<DOC>
	<DOC>NCT01608958</DOC>
	<brief_summary>The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via IV infusion results in a lower mean blood loss compared to IM injection.</brief_summary>
	<brief_title>IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage</brief_title>
	<detailed_description>The study will compare the effect of IV infusion and IM oxytocin administration on the proportion of women who experience blood loss greater than or equal t 350 ml, the proportion of women who experience blood loss greater than or equal to 500 ml, side effects, adverse events and change in hemoglobin pre- to post-delivery. It will also assess whether a bleeding history questionnaire can identify women at risk for excessive bleeding and help to define the distribution of bleeding scores among women with and without excessive bleeding.</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>All women who present in active labor for a live birth at the study hospital will be considered for participation in the study Women who are: Planned or transferred for delivery via Cesarean section Not delivering a live birth Unable to provide informed consent due to mental impairment, distress during labor or other reason Unwilling and/or unable to respond to questionnaires about background characteristics and/or bleeding history.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Third stage of labor</keyword>
	<keyword>Hemoglobin</keyword>
	<keyword>Prevention</keyword>
	<keyword>Intravenous</keyword>
	<keyword>Intramuscular</keyword>
</DOC>